Researchers at Memorial Sloan Kettering Cancer Center in New York City and Massachusetts Institute of Technology in Boston have developed a new, three-step system that uses nuclear medicine to target and eliminate colorectal cancer. In this study with a mouse model, researchers achieved a 100% cure rate—without any treatment-related toxic effects. The study is reported in the November featured article in The Journal of Nuclear Medicine...

Yale University researchers have developed a way in which medical imaging could potentially be used to assess a patient’s rupture risk for abdominal aortic aneurysm. Delaying surgical treatment can be life-threatening, and this new type of imaging could allow physicians to diagnose disease and better plan its management. The study is presented in The Journal of Nuclear Medicine.

Blood clots in veins and arteries can lead to heart attack, stroke, and pulmonary embolism, which are major causes of mortality. In the featured article of The Journal of Nuclear Medicine (JNM), German researchers show that targeting GPIIb/IIIa receptors, the key receptor involved in platelet clumping, with a 18F labeled ligand is a promising approach for diagnostic imaging. Current imaging modalities rely on structural characteristics,...